Senti Biosciences Holdings Inc. Common Stock (SNTI)

About SNTI

Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company's lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications wit…

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Employees

39

Website

www.sentibio.com

Fundamentals

1-day range

$0.4301$0.4776

Market cap

$11.18M

P/E (trailing)

—

P/E (forward)

-0.49

EPS (trailing)

$-1.82

Dividend yield

—

Beta

—

Avg. volume

252.3K

Forecasts

2 analyst ratings

Senti Biosciences Holdings Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• SNTI

  Senti Biosciences Holdings Inc. Common Stock

  $0.377

  ▼ 0.26%
  Market cap $11.18MP/E —
  $0.333$2.88
• INTS

  Intensity Therapeutics Inc. Common stock

  $4.25

  ▲ 0.95%
  Market cap $11.49MP/E —
  $3.51$43.5
• BCDA

  BioCardia Inc. Common Stock

  $1.16

  ▼ 0.85%
  Market cap $10.80MP/E —
  $0.75$2.29
• CRIS

  Curis Inc. Common Stock

  $1.49

  ▲ 2.76%
  Market cap $8.59MP/E —
  $1.4$39
• PASG

  Passage Bio Inc. Common Stock

  $4.52

  ▲ 4.39%
  Market cap $14.11MP/E —
  $3.29$20
• AIM

  AIM ImmunoTech Inc. Common Stock

  $0.2558

  ▲ 2.32%
  Market cap $7.51MP/E —
  $0.1901$2.89
• VIVS

  VivoSim Labs Inc. Common Stock

  $0.29

  ▲ 0.00%
  Market cap $5.53MP/E —
  $0.2625$5.3

P/E shows — for peers not currently carrying a live signal of their own.

• Lu Timothy K · March 9, 2026 · Tax Withholding

  80.7K
• Rajangam Kanya · March 9, 2026 · Tax Withholding

  10.8K